ArticleThe Lancet regional health. Europe2023

Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study.

Anastasia Chatzilena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.